Northern Trust
NSPR icon

Northern Trust’s InspireMD NSPR Stock Holding History

Northern Trust’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,572
Closed -$54.7K – 4527
2026
Q1 		$54.7K Hold
33,572
– – ﹤0.01% 4229
2025
Q4 		$59.8K Hold
33,572
– – ﹤0.01% 4243
2025
Q3 		$80.9K Sell
33,572
-11,748
-26% -$28.5K ﹤0.01% 4184
2025
Q2 		$103K Buy
45,320
+431
+1% +$1.07K ﹤0.01% 4104
2025
Q1 		$121K Sell
44,889
-3,133
-7% -$8.87K ﹤0.01% 4070
2024
Q4 		$126K Buy
48,022
+24,452
+104% +$65.8K ﹤0.01% 4113
2024
Q3 		$63.2K Sell
23,570
-662
-3% -$1.81K ﹤0.01% 4163
2024
Q2 		$60.5K Sell
24,232
-958
-4% -$2.24K ﹤0.01% 4176
2024
Q1 		$59.7K Sell
25,190
-3,248
-11% -$8.76K ﹤0.01% 4194
2023
Q4 		$79.9K Buy
+28,438
New +$81.9K ﹤0.01% 4155
2015
Q4 		– Hold
0
– -$4K – 4303
2015
Q3 		– Hold
0
– – – 4256
2015
Q2 		– Hold
0
– – – 4187
2015
Q1 		– Hold
0
– – – 4265
2014
Q4 		– Hold
0
– – – 4170
2014
Q3 		– Hold
0
– – – 4108
2014
Q2 		– Hold
0
– – – 4036
2014
Q1 		– Hold
0
– – – 3968

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Northern Trust's NSPR Position: Q2 2026 in Review

Northern Trust sold out of InspireMD (NSPR) in Q2 2026, closing a stake of 33,572 shares — an estimated $54.7K sold.

Northern Trust first reported a position in NSPR in Q4 2023 and held it in 10 quarters. The position peaked at $126K in Q4 2024. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Northern Trust reported no remaining InspireMD position as of Q2 2026 after selling out during the quarter.
  • Northern Trust sold 33,572 InspireMD shares in Q2 2026, an estimated $54.7K.
  • Northern Trust first reported a position in InspireMD in Q4 2023 and held it in 10 quarters.
  • Northern Trust's InspireMD position peaked at $126K in Q4 2024.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.